Novo Nordisk A/S News Headlines

NVO 
$44.31
*  
0.01
0.02%
Get NVO Alerts
*Delayed - data as of Oct. 20, 2014 9:46 ET  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Novo Nordisk A/S (NVO) Enters Overbought Territory - Tale of the Tape
1/6/2014 9:51:01 AM - Zacks.com


U.S. Approval for NVO's Tretten - Analyst Blog
12/27/2013 12:02:10 PM - Zacks.com


Arena Pharmaceuticals - A 2014 Story
12/26/2013 4:14:00 PM - Seeking Alpha


Update on NVO's Victoza - Analyst Blog
12/26/2013 1:10:01 PM - Zacks.com


The Obesity Drug Industry Going Into 2014
12/26/2013 6:24:00 AM - Seeking Alpha


Diabetes Programs Now Crucial For Eli Lilly
12/23/2013 8:15:00 AM - Seeking Alpha


An Analysis Of Unilife's Products Shows A Weak Business Case
12/13/2013 9:01:00 AM - Seeking Alpha


Sanofi's Update on Lyxumia - Analyst Blog
12/10/2013 3:23:26 PM - Zacks.com


European Shares Drop on Weak French Data, Fed Worries
12/10/2013 1:33:54 PM - MT Newswires


Positive Phase III Data on Sanofi's U300 - Analyst Blog
12/4/2013 6:05:24 PM - Zacks.com


Data on NVO's Diabetes Drugs - Analyst Blog
12/4/2013 5:04:51 PM - Zacks.com


Update on Glaxo's Avandia - Analyst Blog
11/27/2013 7:06:14 PM - Zacks.com


Update on AstraZeneca's Diabetes Portfolio - Analyst Blog
11/26/2013 5:06:04 PM - Zacks.com


Diabetes Portfolio Update from Novo Nordisk - Analyst Blog
11/25/2013 4:05:57 PM - Zacks.com


Roche's Gazyva Approved in the U.S. - Analyst Blog
11/7/2013 7:39:01 PM - Zacks.com


Stock Upgrades: Green Ink for Green Dot and Greenbrier
11/1/2013 9:18:00 AM - Minyanville


Novo Nordisk Beats on Earnings, Lags Sales - Analyst Blog
11/1/2013 9:13:01 AM - Zacks.com


European Shares Narrowly Mixed, Earnings Help Offset More Hawkish Fed
10/31/2013 12:07:46 PM - MT Newswires


Time To Consider Investing In Scandinavia (EWD, EFNL, NORW, EDEN, GXF)
10/25/2013 3:16:47 PM - Benzinga


FDA Approves Novo Nordisk's NovoEight - Analyst Blog
10/18/2013 5:07:25 PM - Zacks.com


Update on VIVUS' Qsymia - Analyst Blog
10/14/2013 11:40:01 AM - Zacks.com


GSK, Genmab Seek Arzerra EU Approval - Analyst Blog
10/7/2013 5:31:01 PM - Zacks.com


Eli Lily to Cut Costs, Shares Down - Analyst Blog
10/4/2013 12:50:01 PM - Zacks.com


NVO's Diabetes Portfolio Update - Analyst Blog
10/2/2013 3:47:38 PM - Zacks.com


Sanofi's Diabetes Portfolio Update - Analyst Blog
10/2/2013 3:28:01 PM - Zacks.com